{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:14:14Z","timestamp":1779452054758,"version":"3.53.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.rpth.2026.103351","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:32:45Z","timestamp":1768350765000},"page":"103351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence and outcomes of major bleeding among first-time oral factor Xa inhibitor users: multinational observational cohort studies"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9398-4621","authenticated-orcid":false,"given":"Alexander T.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenneke","family":"Leentjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Canbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satarupa","family":"Choudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaozer","family":"Er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chatree","family":"Chai-Adisaksopha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas C.","family":"Dover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jil Billy","family":"Mamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsh K.","family":"Randhawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Beekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Scherg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Arenillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig I.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.103351_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1055\/s-0042-1756702","article-title":"Letter to the editor: 10-year evolution in worldwide usage of anticoagulant drugs","volume":"49","author":"Lippi","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2026.103351_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026723","article-title":"Trends in oral anticoagulant use among 436 864 patients with atrial fibrillation in community practice, 2011 to 2020","volume":"11","author":"Navar","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.rpth.2026.103351_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6707985","article-title":"Time trends and treatment pathways in prescribing individual oral anticoagulants in patients with nonvalvular atrial fibrillation: an observational study of more than three million patients from Europe and the United States","volume":"2022","author":"Vora","year":"2022","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.rpth.2026.103351_bib4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2026.103351_bib5","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.103351_bib6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.103351_bib7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.103351_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.thromres.2017.12.003","article-title":"Current evidence of oral anticoagulant reversal: a systematic review","volume":"162","author":"Tornkvist","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.103351_bib9","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/pds.2109","article-title":"An automated database case definition for serious bleeding related to oral anticoagulant use","volume":"20","author":"Cunningham","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.rpth.2026.103351_bib10","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/eurheartj\/ehu083","article-title":"Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial","volume":"35","author":"Piccini","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2026.103351_bib11","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.3390\/jcm13082277","article-title":"Comparing the real-world and clinical trial bleeding rates associated with oral anticoagulation treatment for atrial fibrillation","volume":"13","author":"Gue","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.rpth.2026.103351_bib12","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.amjmed.2018.12.023","article-title":"Comparative stroke, bleeding, and mortality risks in older Medicare patients treated with oral anticoagulants for nonvalvular atrial fibrillation","volume":"132","author":"Graham","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.rpth.2026.103351_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fcvm.2019.00109","article-title":"Platelet function in aging","volume":"6","author":"Le Blanc","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.rpth.2026.103351_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.acvd.2019.12.003","article-title":"The difficult balance between thrombosis and bleeding after transcatheter aortic valve replacement: a translational review","volume":"113","author":"Trimaille","year":"2020","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.rpth.2026.103351_bib15","first-page":"968","article-title":"Major bleeding risk during anticoagulation with warfarin, dabigatran, apixaban, or rivaroxaban in patients with nonvalvular atrial fibrillation","volume":"23","author":"Adeboyeje","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.rpth.2026.103351_bib16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ejvs.2021.10.054","article-title":"Editor\u2019s choice\u2014severe bleeding risks of direct oral anticoagulants in the prevention and treatment of venous thromboembolism: a network meta-analysis of randomised controlled trials","volume":"63","author":"Chen","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.rpth.2026.103351_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003725","article-title":"Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation","volume":"5","author":"Yao","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.rpth.2026.103351_bib18","article-title":"Clinical and health care resource use burden of hospitalizations for oral factor Xa inhibitor-associated major bleeding: a real-world analysis of Medicare beneficiaries","volume":"4","author":"Williams","year":"2023","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"10.1016\/j.rpth.2026.103351_bib19","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/bloodadvances.2020003560","article-title":"Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry","volume":"5","author":"Bassand","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.103351_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jamaneurol.2024.0221","article-title":"Time to anticoagulation reversal and outcomes after intracerebral hemorrhage","volume":"81","author":"Sheth","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.rpth.2026.103351_bib21","article-title":"Lower mortality with andexanet alfa vs 4-factor prothrombin complex concentrate for factor Xa inhibitor-related major bleeding in a U.S. hospital-based observational study","volume":"7","author":"Dobesh","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103351_bib22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ajem.2017.08.042","article-title":"Management of factor Xa inhibitor-associated life-threatening major hemorrhage: a retrospective multi-center analysis","volume":"36","author":"Milling","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.rpth.2026.103351_bib23","article-title":"Using care bundles to improve health care quality","author":"Resar","year":"2012","journal-title":"IHI Innovation Series white paper"},{"key":"10.1016\/j.rpth.2026.103351_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/23969873231220235","article-title":"Acute care bundles should be used for patients with intracerebral haemorrhage: an expert consensus statement","volume":"9","author":"Parry-Jones","year":"2024","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.rpth.2026.103351_bib25","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/STROKEAHA.123.043033","article-title":"Code ICH: a call to action","volume":"55","author":"Li","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2026.103351_bib26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.25546","article-title":"An intracerebral hemorrhage care bundle is associated with lower case fatality","volume":"86","author":"Parry-Jones","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rpth.2026.103351_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(23)00806-1","article-title":"The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial","volume":"402","author":"Ma","year":"2023","journal-title":"Lancet"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926000099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926000099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:03:14Z","timestamp":1779451394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926000099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2475037926000099"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.103351","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and outcomes of major bleeding among first-time oral factor Xa inhibitor users: multinational observational cohort studies","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.103351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103351"}}